
Astiride MP 1mg/500mg/15mg Tablet SR
Marketer
Astakind Biotech Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Astiride MP 1mg/500mg/15mg Tablet SR
Combiflex-DM 1mg/500mg/15mg extended-release tablets offer a multi-component approach to managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Combiflex-DM. Ingestion with food is recommended to mitigate gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, omit the missed dose and resume the regular schedule. Never double the dose. Excessive intake may trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals elevates the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common adverse events include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals must seek medical counsel before use. Baseline kidney function assessments will be performed before treatment initiation. Limit alcohol consumption during therapy to minimize the potential for adverse effects.
Primary Ingredients of Astiride MP 1mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Astiride MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Astiride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. Astiride MP 1mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Astiride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Astiride MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Astiride MP 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or break it. Administer this extended-release tablet with a meal.
How Astiride MP 1mg/500mg/15mg Tablet SR works:
Astiride MP 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple therapy enhances blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Astiride MP 1mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Astiride MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Astiride MP 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Astiride MP 1mg/500mg/15mg SR tablets to individuals with kidney impairment; dosage modification may be necessary. Severe kidney disease contraindicates the use of Astiride MP 1mg/500mg/15mg SR tablets. Physician consultation is recommended. Kidney function should be regularly assessed during treatment with this medication.
LiverCAUTION
Patients with hepatic impairment should use Astiride MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is necessary. Astiride MP 1mg/500mg/15mg Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Astiride MP 1mg/500mg/15mg Tablet SR :
Should you forget to take your Astiride MP 1mg/500mg/15mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Astiride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
